APA (7th ed.) Citation

Cummings, J. L., & Frölich, L. (2012). Randomized, double-Blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm2) in Alzheimer’s disease. Dementia and geriatric cognitive disorders, 33(5), . https://doi.org/10.1159/000340056

Chicago Style (17th ed.) Citation

Cummings, Jeffrey L., and Lutz Frölich. "Randomized, Double-Blind, Parallel-group, 48-week Study for Efficacy and Safety of a Higher-dose Rivastigmine Patch (15 Vs. 10 Cm2) in Alzheimer’s Disease." Dementia and Geriatric Cognitive Disorders 33, no. 5 (2012). https://doi.org/10.1159/000340056.

MLA (9th ed.) Citation

Cummings, Jeffrey L., and Lutz Frölich. "Randomized, Double-Blind, Parallel-group, 48-week Study for Efficacy and Safety of a Higher-dose Rivastigmine Patch (15 Vs. 10 Cm2) in Alzheimer’s Disease." Dementia and Geriatric Cognitive Disorders, vol. 33, no. 5, 2012, https://doi.org/10.1159/000340056.